Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 8

2 Introduction 9

• 2.1 Abdominal Aortic Stent Grafts Overview 9

3 Products under Development 10

• 3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
• 3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
• 3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 12
• 3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 13
• 3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 14

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies 15

• 4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 15
• 4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 16

5 Abdominal Aortic Stent Grafts Companies and Product Overview 18

• 5.1 Affluent Medical SA Company Overview 18
  • 5.1.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.2 Altura Medical Inc Company Overview 21
  • 5.2.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.3 Angiolutions UG Company Overview 24
  • 5.3.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.4 Aortica Corp Company Overview 25
  • 5.4.1 Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.5 BiFlow Medical Ltd Company Overview 26
  • 5.5.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.6 Cook Medical Inc Company Overview 27
  • 5.6.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.7 Cordis Corp Company Overview 31
  • 5.7.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.8 Cytograft Tissue Engineering Inc (Inactive) Company Overview 35
  • 5.8.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.9 Endologix Inc Company Overview 36
  • 5.9.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.10 Endoluminal Sciences Pty Ltd. Company Overview 51
  • 5.10.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
• 5.11 Hadassah Medical Center Company Overview 52
  • 5.11.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.12 JOTEC GmbH Company Overview 53
  • 5.12.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 53
• 5.13 Kawasumi Laboratories Inc Company Overview 56
  • 5.13.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.14 Lombard Medical Technologies Inc. Company Overview 57
  • 5.14.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
• 5.15 Lombard Medical Technologies Ltd Company Overview 58
  • 5.15.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
• 5.16 Medtronic plc Company Overview 64
  • 5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 64
• 5.17 St. Jude Medical LLC Company Overview 67
  • 5.17.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 67
• 5.18 Terumo Aortic Company Overview 68
  • 5.18.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 68
• 5.19 University of Colorado Denver Company Overview 76
  • 5.19.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 76
• 5.20 University of Limerick Company Overview 77
  • 5.20.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 77
• 5.21 Venus MedTech Company Overview 78
  • 5.21.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 78
• 5.22 W. L. Gore & Associates Inc Company Overview 79
  • 5.22.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 79

6 Abdominal Aortic Stent Grafts- Recent Developments 84

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
• 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
• 6.3 Nov 12, 2019: W. L. Gore & Associates to reveal new gender insights from real-world aortic data At 2019 VEITHsymposium 87
• 6.4 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 88
• 6.5 Nov 06, 2019: Endologix reports third quarter 2019 financial results 88

7 Appendix 130

• 7.1 Methodology 130
• 7.2 About GlobalData 133
• 7.3 Contact Us 133

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019" provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Abdominal Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date